| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $2.71 (Beat by $1.88) |
| EPS GAAP Actual | $2.71 (Beat by $1.88) |
| Revenue Actual | $1.0581B |
| Revenue Surprise | Beat by $1058.1M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.89663 |
| EPS GAAP Estimate | $0.89663 |
| Revenue Estimate | $1.047039293B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | 3.965 | 21.06 | 3.9 | 4.03 | 2 |
| Dec 2024 | 3.63 | 23.01 | 3.49 | 3.76 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.84 | -0.07312 | 1.0581B | 4.17% | 0.83M |
| FQ2 2025 (Jun 2025) | 2.15 | 2.15 | 1.06544B | 2.95% | 1065.44M |
| FQ1 2025 (Mar 2025) | 0.99 | 0.99 | 1.07417B | 2.68% | 1074.17M |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 1.09302B | 3.41% | 1093.02M |
| FQ3 2024 (Sep 2024) | 2.33 | 2.33 | 1.01396B | 100% | 1013.96M |
| FQ2 2024 (Jun 2024) | 1.36 | 1.36 | 1.03402B | 1.99% | 1034.02M |
| FQ1 2024 (Mar 2024) | 1.43 | 1.43 | 1.04538B | 1.59% | 1045.38M |
| FQ4 2023 (Dec 2023) | 1.5 | 1.5 | 1.0558B | 2.66% | 1055.8M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.89663
Consensus Revenue Estimates
1.047039293B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.46667 | -- | 1.45151 | 1.47822 | 1 |
| FQ3 2027 (Sep 2027) | 1.11514 | -- | 1.10009 | 1.12763 | 1 |
| FQ2 2027 (Jun 2027) | 1.12213 | -- | 1.10699 | 1.1347 | 1 |
| FQ1 2027 (Mar 2027) | 1.1639 | -- | 1.1482 | 1.17693 | 1 |
| FQ4 2026 (Oct 2026) | 0.97067 | -- | 0.95432 | 0.99196 | 1 |
| FQ3 2026 (Jul 2026) | 1.05118 | 20.09 | 1.03347 | 1.07423 | 1 |
| FQ2 2026 (Jun 2026) | 1.18937 | -80.77 | 1.16492 | 1.22263 | 1 |
| FQ1 2026 (Mar 2026) | 1.04102 | 4.9 | 1.01962 | 1.07013 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.21B | -- | 1.2B | 1.22B | 2 |
| FQ3 2027 (Sep 2027) | 1.13B | -- | 1.12B | 1.14B | 2 |
| FQ2 2027 (Jun 2027) | 1.15B | -- | 1.13B | 1.16B | 2 |
| FQ1 2027 (Mar 2027) | 1.15B | -- | 1.14B | 1.16B | 2 |
| FQ4 2026 (Oct 2026) | 1.08B | -- | 1.07B | 1.1B | 2 |
| FQ3 2026 (Jul 2026) | 1.11B | 5.08 | 1.1B | 1.13B | 2 |
| FQ2 2026 (Jun 2026) | 1.15B | 7.12 | 1.13B | 1.17B | 2 |
| FQ1 2026 (Mar 2026) | 1.1B | 2.42 | 1.08B | 1.12B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.91312 | 0.84 | -0.07312 | -8.7% |
| FQ2 2025 (Jun 2025) | 2.15 | 2.15 | 100% | |
| FQ1 2025 (Mar 2025) | 0.99 | 0.99 | 100% | |
| FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 100% | |
| FQ3 2024 (Sep 2024) | 2.33 | 2.33 | 100% | |
| FQ2 2024 (Jun 2024) | 1.36 | 1.36 | 100% | |
| FQ1 2024 (Mar 2024) | 1.43 | 1.43 | 100% | |
| FQ4 2023 (Dec 2023) | 1.5 | 1.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.06B | $1.06B | $0.83M | 0.08% |
| FQ2 2025 (Jun 2025) | $0B | $1.07B | $1065.44M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.07B | $1074.17M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.09B | $1093.02M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.01B | $1013.96M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.03B | $1034.02M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.05B | $1045.38M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.06B | $1055.8M | 100% |